Funding for this research was provided by:
National Institutes of Health (5 U01 AI103401 05)
National Institute of Allergy and Infectious Diseases (P30AI050409, P30AI027767-31)
Received: 10 March 2020
Accepted: 23 June 2020
First Online: 6 July 2020
Ethics approval and consent to participate
: The institutional review boards at the University of Alabama at Birmingham, University of Mississippi Medical Center, Emory University, State University of New York - Downstate Health Sciences University, University of North Carolina at Chapel Hill, and the University of Illinois at Chicago approved the study protocol. Informed consent was obtained from all study participants prior to focus group or interview participation.
: Not applicable given that all data is de-identified and does not include individual participant data.
: The authors declare that they have no competing interests.